Search Results 351-360 of 13323 for monoclonal antibody

1. Anifrolumab-fnia (intravenous route, subcutaneous route) - Side effects & dosage - Mayo Clinic

   It is a monoclonal antibody that changes the immune system to help control lupus symptoms. This medicine is available only with your doctor's prescription ...

2. A Study Of TRX319 In Subjects With Primary Or Secondary Progressive Multiple Sclerosis - Mayo Clinic

   anti-CD20 monoclonal antibody (mAb) that depletes B cells, is currently. the only approved drug in the United States for primary progressive MS. (PPMS) ...

3. Rituximab-arrx (intravenous route) - Side effects & uses - Mayo Clinic

   Rituximab-arrx is a monoclonal antibody. Rituximab-arrx injection is also used together with other medicines (eg, fludarabine and cyclophosphamide) to treat ...

4. Expert Alert: What's on the horizon for multiple myeloma and other blood cancers - Mayo Clinic News Network

   The safety and efficacy of REGN5458, a monoclonal antibody, which has been used in people who already have been treated for multiple myeloma. Several ...

5. A Study of Adding AMG 479 to First Line Chemotherapy in Patients with Optimally Debulked Epithelial Ovarian Cancer - Mayo Clinic

   The purpose of this study is to determine the value of adding AMG 479 (a fully human monoclonal antibody against IGF-1R) to paclitaxel and carboplatin ...

6. Radiation Therapy, Paclitaxel, And Carboplatin With Or Without Trastuzumab In Treating Patients With Esophageal Cancer - Mayo Clinic

   Monoclonal antibodies, such as trastuzumab, can block tumor growth in different ways. ... monoclonal antibody; Previous history of congestive heart failure ...

7. Rituximab, Cyclophosphamide, Bortezomib, and Dexamethasone in Treating Patients with Relapsed or Refractory Low-Grade Follicular Lymphoma, Waldenstrom Macroglobulinemia, or Mantle Cell Lymphoma - Mayo Clinic

   RATIONALE: Monoclonal antibodies, such as rituximab, can block cancer growth in different ways. Some block the ability of cancer cells to grow and spread ...

8. Clinical trials - Oncology (Medical)

   Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer ...

9. Oncology (Medical) - Clinical trials

   Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer ...

10. Anetumab Ravtansine And Atezolizumab In Treating Participants With Advanced Non-small Cell Lung Cancer - Mayo Clinic

    Monoclonal antibodies, such as anetumab ravtansine and atezolizumab, may interfere with the ability of tumor cells to grow and spread. Participation ...